Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients After Chemoradiation: Its Clinical Implications

BACKGROUND: We have limited knowledge of the geographic distribution of resistant EAC in the resected specimen and its clinical importance can be enormous. METHOD: We selected patients with baseline stage III EAC who had chemoradiation followed by surgery, and had residual EAC (resistant cases only)...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncology
Hlavní autoři: Neishaboori, Nastaran, Wadhwa, Roopma, Nogueras-González, Graciela M., Elimova, Elena, Shiozaki, Hironori, Sudo, Kazuki, Charalampakis, Nikolaos, Hiremath, Adarsh, Lee, Jeffrey H., Bhutani, Manoop S., Weston, Brian, Blum, Mariela A., Rogers, Jane E., Garris, Jeana L., Rice, David C., Komaki, Ritsuko, Swisher, Stephen G., Skinner, Heath D., Hofstetter, Wayne L., Ajani, Jaffer A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4498973/
https://ncbi.nlm.nih.gov/pubmed/25765719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000371889
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky